Mangoceuticals (MGRX) Interest Expenses (2025)
Mangoceuticals recorded quarterly Interest Expenses of $19663.0 in Q4 2025, down 74.08% quarter-over-quarter from $75850.0 in Q3 2025.
Mangoceuticals' Interest Expenses history runs 1 years deep, the most recent figure standing at $19663.0 for Q4 2025.
- In Q4 2025, Interest Expenses changed N/A year-over-year to $19663.0; the TTM figure through Mar 2026 stood at $117213.0 (up 955.57% YoY), while the FY2025 annual figure was $103513.0, up 655.57% from the prior year.
- Interest Expenses came in at $19663.0 for Q4 2025 at Mangoceuticals, down from $75850.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $75850.0 in Q3 2025 to a low of -$13700.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 38.62 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 12.59 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 20.65 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19,663.00 |
| Dec 31, 2025 | 19,663.00 |
| Sep 30, 2025 | 75,850.00 |
| Sep 30, 2025 | 75,850.00 |
| Jun 30, 2025 | 21,700.00 |
| Jun 30, 2025 | 21,700.00 |
| Mar 31, 2025 | -13,700.00 |
| Mar 31, 2025 | -13,700.00 |